M K Proteins Q2 Results 2026: PAT ₹1 Cr +16%, Revenue ₹44 Cr +37%
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
- Revenue
- ₹44Cr
- +37.1% YoY
- −61.4% QoQ
- Net profit
- ₹1Cr
- +16% YoY
- −37% QoQ
- Margin
- 3.3%
- +0.1 pp YoY
- +1.1 pp QoQ
Top 10 Agricultural Food & other Products companies on management guidance
See the sector's top 10 — free with your mobile number.
M K Proteins Ltd Q2 FY27 key numbers
- Revenue
- Revenue from operations for the quarter ended 30th September 2026: ₹4446.28 Lakhs.
As stated in M K Proteins Ltd's Q2 FY27 results statement · published 13 Nov 2026. Reported figures, not investment advice.
Based on M K Proteins Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from operations for the quarter ended 30th September 2026: ₹4446.28 Lakhs. EBITDA for the quarter ended 30.09.2026: ₹250.33 Lakhs (from Page 3, Total comprehensive income and other profit figures are indirect; EBITDA is ₹250.33 reported explicitly in the statement).
From M K Proteins Ltd's Q2 FY27 earnings-call transcript · updated 13 Nov 2026.
How did M K Proteins' revenue grow in the September 2026 quarter?
- Revenue from operations for the quarter ended 30th September 2026: ₹4446.28 Lakhs
- Revenue from operations for the quarter ended 30th September 2025: ₹3243.03 Lakhs
- Year-on-year revenue growth for the quarter: ₹4446.28 Lakhs vs ₹3243.03 Lakhs (approx. 37% increase)
What happened to M K Proteins' margins in Q2 FY27?
EBITDA for the quarter ended 30.09.2026: ₹250.33 Lakhs (from Page 3, Total comprehensive income and other…
Locked: what M K Proteins Ltd said on margins
Also locked on this page: capex, fundraising, order book
Free account, 30 seconds. No card needed.
What capex is M K Proteins planning?
See what M K Proteins Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Agricultural Food & other Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is M K Proteins raising money or cutting debt?
The Cash Flow Statement (Page 8) shows changes in borrowings:
Locked: what M K Proteins Ltd said on fundraising
Also locked on this page: margins, capex, order book
Free account, 30 seconds. No card needed.
How big is M K Proteins' order book?
See what M K Proteins Ltd said on order book & pipeline — free account, 30 seconds.
M K Proteins Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the table below.
M K Proteins Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| Revenue | 44 | 32 | +37.1% | 115 | -61.4% |
| Operating profit (EBITDA) | 1 | 1 | +41.3% | 3 | -41.4% |
| Operating margin | 3.3% | 3.2% | +0.1 pp | 2.2% | +1.1 pp |
| Profit before tax | 1 | 1 | +17% | 2 | -36.8% |
| Net profit (PAT) | 1 | 1 | +16% | 1 | -37% |
| EPS (₹) | 0.02 | 0.02 | 0% | 0.04 | -50% |
Source: M K Proteins Ltd's results filing to NSE (standalone), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹115 Cr, net profit ₹1 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Agricultural Food & other Products
- Marico Q2 FY27 results
- Tata Consumer Q2 FY27 results
- AWL Agri Business Q2 FY27 results
- L T Foods Q2 FY27 results
- Balrampur Chini Q2 FY27 results
- CCL Products Q2 FY27 results
- KRBL Q2 FY27 results
- Gujarat Ambuja Exports Q2 FY27 resultsRevenue ₹1,451.33 Cr · PAT ₹131.99 Cr
All Q2 FY27 results | Agricultural Food & other Products rankings
Continue your research
Others in Agricultural Food & other Products this season
- Jay Shree Tea (Q2 FY27)
Consolidated Revenue from Operations for Q2 FY27: ₹27,315 lakhs, up from ₹26,745 lakhs in Q2 FY26 (approx. Key results statement takeaways from Jay Shree Tea &…
- Regaal Resources (Q2 FY27)
Q2 FY27 Operating Income (Revenue) was ₹3,166 million, up 56.6% year-on-year (YoY) from ₹1,902 million in Q2 FY26. Key investor presentation takeaways from Rega
- Chamanlal Setia (Q2 FY27)
Q2FY27 net sales: ₹328.8 crore, up 20.4% YoY (Page 10) . Key investor presentation takeaways from Chamanlal Setia Exports Ltd's Q2 FY27 investor presentation —
- KCP Sugar & Industries Corporation (Q2 FY27)
5,486.83 Lakhs in Q2 2025, a ~20% increase year-on-year. Key results statement takeaways from KCP Sugar & Industries Corporation Ltd's Q2 FY27 results statement
Potential multibaggers · Q2 FY27
Potential multibaggers in Agricultural Food & other Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
M K Proteins Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were M K Proteins Ltd Q2 FY27 results?
Revenue from operations for the quarter ended 30th September 2026: ₹4446.28 Lakhs. EBITDA for the quarter ended 30.09.2026: ₹250.33 Lakhs (from Page 3, Total comprehensive income and other profit figures are indirect; EBITDA is ₹250.33 reported explicitly in the statement).
What is M K Proteins Ltd share price analysis?
M K Proteins Ltd currently shows a neutral. The stock trades at a P/E of 30.5 with a market cap of ₹143 Cr. Investors should review the full earnings analysis for detailed insights.
Keep M K Proteins Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.